PRINCEPS DIVISION
Qeginus® Quetiapine Fumarate Tablets
PRODUCT OVERVIEW
About Qeginus®
Quetiapine is a prescription medicine used in the management of certain psychiatric conditions, subject to the approved indications and prescribing information applicable to the specific product and strength.
This page provides an overview of the QEGINUS® product range, its available strengths and important safety information for healthcare professionals. Treatment decisions, dosage and monitoring must be determined by a qualified prescriber.
Composition & Therapeutic Profile
QEGINUS® is available in three tablet strengths to support prescribing according to the individual patient’s clinical requirements and approved prescribing information.
Composition
25 mg | 50 mg | 100 mg
Therapeutic Class
A prescription medicine belonging to the atypical antipsychotic class.
Therapeutic Focus
Product information for approved psychiatric indications, based on the applicable prescribing information.
How QEGINUS® Works
Quetiapine is an atypical antipsychotic medicine that acts on specific neurotransmitter receptors in the brain, particularly serotonin and dopamine receptors. These neurotransmitter systems are involved in regulating several aspects of brain function.
Its pharmacological activity forms the basis for its use in certain psychiatric conditions, as specified in approved prescribing information. The selection of treatment and ongoing monitoring must be guided by a qualified psychiatrist or other authorised prescriber.
Key points
- Atypical Antipsychotic Medicine
- Acts on Serotonin and Dopamine Receptors
- Prescription-Only Medicine
- - Requires Professional Assessment and Monitoring
Clinical & Therapeutic Areas
QEGINUS® contains quetiapine fumarate, a prescription medicine used for certain psychiatric conditions. Its approved therapeutic applications depend on the specific product registration and prescribing information. The appropriate indication, treatment plan and monitoring should always be determined by a qualified healthcare professional.

Approved Indications
Refer to the approved prescribing information for the specific indications applicable to QEGINUS®.

Individualised Treatment
Treatment decisions should be based on the patient's clinical condition and professional assessment.

Ongoing Monitoring
Appropriate clinical monitoring is important throughout treatment, as directed by the prescribing professional.
Frequently Asked Questions About QEGINUS®
QEGINUS® is a prescription medicine containing quetiapine fumarate, an atypical antipsychotic medicine.
QEGINUS® is available in three tablet strengths: 25 mg, 50 mg and 100 mg.
Quetiapine belongs to the atypical antipsychotic class of medicines.
Yes. QEGINUS® is a prescription medicine and should be used only under the guidance of a qualified healthcare professional.
No. Treatment should not be started, stopped or adjusted without consulting the prescribing healthcare professional.
Discover Our Specialty Pharmaceutical Portfolio
Explore the MERGA and PRINCEPS divisions of Seginus Pharma and discover our portfolio of pharmaceutical products across key therapeutic areas.